WisdomTree China ex-State-Owned Enterprises Fund (CXSE)
| Assets | $783.05M |
| Expense Ratio | 0.32% |
| PE Ratio | 23.42 |
| Shares Out | 22.73M |
| Dividend (ttm) | $0.54 |
| Dividend Yield | 1.56% |
| Ex-Dividend Date | Dec 23, 2022 |
| Payout Ratio | 35.88% |
| 1-Year Return | -17.15% |
| Volume | 47,742 |
| Open | 34.22 |
| Previous Close | 34.38 |
| Day's Range | 34.10 - 34.55 |
| 52-Week Low | 26.31 |
| 52-Week High | 43.71 |
| Beta | 0.56 |
| Holdings | 202 |
| Inception Date | Sep 19, 2012 |
About CXSE
The WisdomTree China ex-State-Owned Enterprises Fund (CXSE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market-cap-weighted index of Chinese companies that are not state-owned, defined as government ownership of less than 20%. CXSE was launched on Sep 19, 2012 and is managed by WisdomTree.
Top 10 Holdings
35.87% of assets| Name | Symbol | Weight |
|---|---|---|
| Alibaba Group Holding Ltd Ordinary Shares | 9988.HK | 9.22% |
| Meituan Class B | 3690.HK | 4.90% |
| Ping An Insurance (Group) Co. of China Ltd Class H | 2318.HK | 4.45% |
| NetEase Inc Ordinary Shares | 9999.HK | 3.68% |
| JD.com Inc Ordinary Shares - Class A | 9618.HK | 2.84% |
| WuXi Biologics (Cayman) Inc | 2269.HK | 2.51% |
| PDD Holdings Inc. | PDD | 2.34% |
| Contemporary Amperex Technology Co Ltd Class A | 300750.SZ | 2.29% |
| Ping An Insurance (Group) Co. of China Ltd Class A | 601318.SS | 2.00% |
| BeiGene Ltd Ordinary Shares | 6160.HK | 1.66% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2022 | $0.04229 | Dec 29, 2022 |
| Sep 26, 2022 | $0.110 | Sep 29, 2022 |
| Jun 24, 2022 | $0.230 | Jun 29, 2022 |
| Mar 25, 2022 | $0.155 | Mar 30, 2022 |
| Dec 27, 2021 | $0.03871 | Dec 30, 2021 |
| Sep 24, 2021 | $0.140 | Sep 29, 2021 |
News
5 ETFs to Tap on China's High Growth Prospects
China's economy will likely expand 5.2% this year as compared to last year's 3%, per a latest IMF report.
Why This ETF Is a Valid China Play
As has been widely documented, Chinese stocks are rebounding to start 2023, but seasoned investors know that it pays to be judicious in developing economies, including China.
Why China Reopening ETF CXSE Can Perform in 2023
It may be early in the year, but it's possible we already may be seeing a key theme in China loosening its zero-COVID policies. As one of the world's economic pillars, the country will be aiming to re...
5 ETFs Riding Higher on a China Stock Rally
After a $3.9 trillion rout, Chinese stocks have staged a strong comeback this year. The MSCI China Index has risen 12.4% in the initial weeks of 2023, marking the best start to a year since 1996.
Eye China Consumers in Reopening in CXSE
While China's Communist Party meeting earlier this year put fear into markets, recent news that the nation is considering finally loosening up its COVID-19 policies may offer the nation's economy a bo...
A Guide to the WisdomTree Rebalance Making Waves in EM
Emerging market investors took notice this week when market dislocations on Monday revolving around Chinese companies caused sudden concern. The moves were due to a WisdomTree rebalance of its ex-stat...
Smart ETF Strategies for International Market Exposure Today
Exchange traded fund investors should consider the benefits of currency hedging in international allocations to help access a “truer” exposure to foreign markets.
WisdomTree Launches Ex-China, Ex-SOE Emerging Market ETF
WisdomTree has announced today the launch of its latest fund on the NYSE, the WisdomTree Emerging Markets ex-China Fund (XC), for investors who are interested in emerging market allocation, who wish t...
See Opportunity in China? CXSE Invests in Non-State-Owned Companies
The recent relaxing of strict COVID-19 requirements in China, alongside the indicators that the regulatory cycle in China could be easing and the stimulus that China is currently pumping into its econ...
Chinese Tech Quietly Gains as U.S. Equities Panic
ETFs tracking Chinese technology and consumer discretionary firms have had a relatively strong month, producing a near-mirror image of those sectors being slammed by inflation and rate hikes in the U....
Biotech and Delisting Risk From China's Perspective with WisdomTree
Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D.
China Narrative Is Changing, Could Boost CXSE
For over a year now, the narrative on Chinese equities has largely been gloomy, as highlighted by the MSCI China Index shedding a third of its value over the past 12 months. Much of that has to do wit...
Top 5 China ETFs by Inflows for 2021
It's been a volatile year for foreign investors with exposure to China, but one fund has had an absolutely meteoric year despite negative price action driven by regulatory crackdowns. Here's a look at...
China Script Flipped This Year, but Sound ETF Ideas Are Still Out There
This year, China's renewed emphasis on industry-level regulations is weighing on stocks there and the related exchange traded funds. While the Chinese Communist Party (CCP) has a history of targeting ...
How China's Zero-Tolerance COVID-19 Policy Affects Stocks
China has a strong stance against the coronavirus. In simple terms, Beijing has a zero-tolerance policy regarding COVID-19.
Are Chinese Stocks Almost Buys? It's a Matter of Perspective
Nearly nine months into the year, China is teaching global investors some hard lessons in 2021. Primarily, when the Chinese Communist Party (CCP) wants to crack the regulatory whip, it can and will do...
As Retail Investors Pour into Chinese Stocks Again, Consider CXSE
Saying Chinese stocks are encountering controversy this year is an understatement. Between delisting chatter in the U.S. and Beijing's regulatory crackdown on internet companies, many of which raised ...
Bank of America: This China ETF Looks ‘Most Attractive'
With Beijing clamping down on Chinese internet firms, tech organizations, and for-profit tutoring companies, these are perilous times for investors with exposure to the world's second-largest economy....
Check In with CXSE as a China Rebound Idea
Amid speculation that more Chinese companies will face delisting in the U.S. as Beijing continues to regulate domestic companies, Chinese stocks are being crimped. The MSCI China Index is lower by alm...
7 China Funds for Investors Wary of Internet Giants
Barron's screened Morningstar Direct for China-focused funds with less than a third of assets in six big internet companies.
As Governments Scrutinize Chinese SOEs, Investors Should Too
Chinese stocks offer plenty of promise and growth potential, but integral to allocating to the country is avoiding sources of controversy and geopolitical risk, including state-owned enterprises (SOEs...
Investing in Chinese Tech: The Proverbial Risk/Reward Scenario
Alibaba (NYSE:BABA) recently drew the ire of Beijing, reminding investors that political risk is an important issue to consider in emerging markets. Still, the WisdomTree China ex-State-Owned Enterpri...
ETF of the Week: WisdomTree China ex-State-Owned Enterprises Fund (CXSE)
ETF Trends CEO Tom Lydon discussed the WisdomTree China ex-State-Owned Enterprises Fund (CXSE) on this week's “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show. CXSE seeks to track the ...
China Continues to Be Risky for Investors. What to Expect in 2021.
China risks are on multiple fronts—from the technology rivalry with the U.S. to more regulatory scrutiny inside China of internet giants.